Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Dec 1997, 3104-3108, Vol 35, No. 12
PJ Masendycz, EA Palombo, RJ Gorrell and RF Bishop
This study was designed to evaluate three techniques most commonly used to
identify the VP4 (P) types of human group A fecal rotaviruses. The
techniques included PCR with nested primers and hybridization with PCR-
generated probes (to determine the P genotypes). The results obtained by
these genetic techniques were evaluated against those obtained by an enzyme
immunoassay (EIA) incorporating neutralizing monoclonal antibodies (N-MAbs)
reacting with three major human P serotypes (serotypes P1A, P1B, and P2A).
The P types of the rotaviruses present in 102 fecal specimens were
determined under code by each of the three assays. The specificity of each
assay was evaluated against a "gold standard" putative P type (P serotype
and genotype) deduced from knowledge of the VP7 (G) type and the origin of
the fecal specimen. Overall comparison of the results showed respective
sensitivities and specificities of 92 and 92% for reverse
transcription-PCR, 80 and 99% for hybridization, and 73 and 91% for EIA
with N-MAbs. The hybridization assay retained high sensitivity with
specimens stored for > or = 10 years. Hybridization assays with
nonradioactive probes are relatively inexpensive and are suited for use in
developing countries. In summary, both genetic assays showed high
sensitivities and specificities in assigning a P type to human fecal
rotavirus strains. Further evaluation of the EIA with N-MAbs is required,
together with incorporation of new N-MAbs for the detection of the
additional P types detected in developing countries.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Comparison of enzyme immunoassay, PCR, and type-specific cDNA probe techniques for identification of group A rotavirus gene 4 types (P types) [In Process Citation]
Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Melbourne, Victoria, Australia.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|